Ensure Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.41 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.40 M
- Revenue Growth 28.61%
- Profit Growth 97.73%
- Ebitda 273.84%
- Net Worth -0.69%
- Total Assets -4.63%
About Ensure Biotech
Ensure Biotech Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 2004 and has a history of 20 years and one month. Its registered office is in Hyd-76., Telangana.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.41 M.
The company currently has active open charges totaling ₹4.40 M.
Venkat Pagidi and Anitha Pagidi serve as directors at the Company.
Company Details
- Location Hyd-76., Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2004PTC045000
- Company No.
045000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ensure Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkat Pagidi  | Managing Director | 29-Dec-2004 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anitha Pagidi | Director | 21-May-2018 | Current |
Financial Performance of Ensure Biotech.
Ensure Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.61% increase. The company also saw a substantial improvement in profitability, with a 97.73% increase in profit. The company's net worth dipped by a decrease of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ensure Biotech?
In 2019, Ensure Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.40 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.44 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2005 | State Bank Of India | ₹4.40 M | Open |
How Many Employees Work at Ensure Biotech?
Unlock and access historical data on people associated with Ensure Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ensure Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ensure Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
